| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active control comparisons: The ideal trial design
|
Brodie, Martin J.
|
|
2006
|
68 |
1 |
p. 69-73
5 p.
|
artikel
|
| 2 |
Active control trials: Endpoints beyond conventional efficacy and tolerability measures
|
Perucca, Emilio
|
|
2006
|
68 |
1 |
p. 73-74
2 p.
|
artikel
|
| 3 |
Adverse psychiatric effects of antiepileptic drugs
|
Gilliam, Frank G.
|
|
2006
|
68 |
1 |
p. 67-69
3 p.
|
artikel
|
| 4 |
Antiepileptic drugs trials: Neonates and infants
|
Pellock, Jack
|
|
2006
|
68 |
1 |
p. 42-45
4 p.
|
artikel
|
| 5 |
Antiepileptic drug trials in the elderly
|
Leppik, I.
|
|
2006
|
68 |
1 |
p. 45-48
4 p.
|
artikel
|
| 6 |
Antiepileptic drug use and epileptic seizures in elderly nursing home residents: A survey in the province of Pavia, Northern Italy
|
Galimberti, Carlo Andrea
|
|
2006
|
68 |
1 |
p. 1-8
8 p.
|
artikel
|
| 7 |
Bioequivalence in development of antiepileptic drugs
|
Sommerville, Kenneth W.
|
|
2006
|
68 |
1 |
p. 82-85
4 p.
|
artikel
|
| 8 |
Clinical trials for prevention of epileptogenesis
|
Herman, Susan T.
|
|
2006
|
68 |
1 |
p. 35-38
4 p.
|
artikel
|
| 9 |
Cognitive and memory effects of the new antiepileptic drugs
|
Meador, Kimford J.
|
|
2006
|
68 |
1 |
p. 63-67
5 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2006
|
68 |
1 |
p. iii-
1 p.
|
artikel
|
| 11 |
FDA update
|
Katz, Russell
|
|
2006
|
68 |
1 |
p. 85-94
10 p.
|
artikel
|
| 12 |
Historical control withdrawal to monotherapy
|
French, Jacqueline
|
|
2006
|
68 |
1 |
p. 74-77
4 p.
|
artikel
|
| 13 |
Historical data in the design and interpretation of trials with newly diagnosed patients
|
Baulac, Michel
|
|
2006
|
68 |
1 |
p. 77-81
5 p.
|
artikel
|
| 14 |
How trial designs impact on guidelines
|
French, Jacqueline A.
|
|
2006
|
68 |
1 |
p. 56-60
5 p.
|
artikel
|
| 15 |
Introduction
|
French, Jacqueline
|
|
2006
|
68 |
1 |
p. 21-22
2 p.
|
artikel
|
| 16 |
Large clinical trials in epilepsy: Funding by the NIH versus pharmaceutical industry
|
Privitera, Michael
|
|
2006
|
68 |
1 |
p. 52-56
5 p.
|
artikel
|
| 17 |
Models of epileptogenesis in adult animals available for antiepileptogenesis drug screening
|
Dichter, Marc A.
|
|
2006
|
68 |
1 |
p. 31-35
5 p.
|
artikel
|
| 18 |
Molecular targets versus models for new antiepileptic drug discovery
|
Rogawski, Michael A.
|
|
2006
|
68 |
1 |
p. 22-28
7 p.
|
artikel
|
| 19 |
Obtaining pediatric indications for new anti-epileptic drugs: How and when
|
Garofalo, Elizabeth
|
|
2006
|
68 |
1 |
p. 38-42
5 p.
|
artikel
|
| 20 |
Pediatric epilepsy models
|
Jensen, Frances E.
|
|
2006
|
68 |
1 |
p. 28-31
4 p.
|
artikel
|
| 21 |
Proof of principle studies
|
Schmidt, Bernd
|
|
2006
|
68 |
1 |
p. 48-52
5 p.
|
artikel
|
| 22 |
Seizure anticipation, states of consciousness and marginal predictability in temporal lobe epilepsy
|
Li, Dingzhou
|
|
2006
|
68 |
1 |
p. 9-18
10 p.
|
artikel
|
| 23 |
Table of contents
|
|
|
2006
|
68 |
1 |
p. 19-21
3 p.
|
artikel
|
| 24 |
Therapeutic drug monitoring assay development to improve efficacy and safety
|
Pippenger, Charles E.
|
|
2006
|
68 |
1 |
p. 60-63
4 p.
|
artikel
|
Tijdschrift beschrijving